QPS Neuropharmacology

QPS Neuropharmacology is a division of QPS that focuses on preclinical studies in CNS diseases, Orphan Diseases and Mental Disorders. Our profound expertise in neuroscience and two decades of experience in contract research results in a sustainable advantage for our customers. The on-site availability of highly predictive disease models and unparalleled experience with studies performed for biopharmaceutical companies of all sizes makes QPS Neuropharmacology the first choice for most CNS drug development needs. QPS Neuropharmacology offers a sophisticated range of validated transgenic and non-transgenic in vivo and in vitro models that guarantee an in depth profiling of your new chemical or biological compounds using both novel and established drug targets that play a role in the complex etiology of neurodegenerative diseases.